Get The Facts

In 2009 alone, more than 150,000 African Americans will be diagnosed with cancer, and more than 63,000 African Americans will die of cancer.


Historically, African American men and women have a higher incidence of lung, prostate and breast cancers than White men and women. You have a chance to directly play a role in research that could lead to lifesaving differences, by participating in the Cancer Prevention Study-3 (CPS-3).

 

 

Purpose of CPS-3

The American Cancer Society’s Research Department is recruiting a diverse group of 500,000 men and women across the US and Puerto Rico for a new research study, the Cancer Prevention Study-3 (CPS-3). CPS-3 will help us better understand the genetic, behavioral, environmental, and lifestyle factors that cause or prevent cancer, ultimately eliminating cancer as a major health concern for future generations.

 

 

 

Why Should I Participate?


If not you, then who?
Has never been diagnosed with cancer
(similar to a doctor’s visit)
lifestyle, behaviors, and other factors
ated to your health.
udies.
We can only study people who enroll and participate. There is little information about how cancer affects African Americans because of lack of participation in studies like CPS-3. CPS-3 will help researchers produce more concrete information about what behaviors, lifestyles, and habits prevent cancer. CPS-3 may also produce information that could lead to earlier detection to lessen the burden of cancer in the community.
This is your opportunity to prepare a cancer-free legacy for generations to come.

 

 

 

 

 

 

 

 

 

 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Who is eligible to participate?


Anyone who:

Is willing to make a long-term commitment to the study, by completing a follow-up survey every few years, over the next 20-30 years.

-Is between 30 and 65 years old

-Has never been diagnosed with cancer

 

Overview of CPS-3

Click for flyer and FAQs

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Next Steps

 

To find out how you can contribute to a cancer-free future, visit the Cancer Prevention Study-3 website at www.cancer.org/cps3 or call Bro. David Saunders at (510) 464-8146. You can also email us at david.saunders@cancer.org

Interested in Fighting back against cancer?

link

link

 

 

 

 

 

 

What does study participation involve?


The enrollment process is simple and involves two phases. At a local enrollment event,
you will be asked to:

Read and sign an informed consent form
Complete a brief written survey
Provide a waist measurement
Give a small blood sample
(simalar to the doctor's Visit)

At home you will complete a more-detailed survey, which will ask for information on lifestyle, behaviors, and other factors related to your health.

We will continue to mail follow-up surverys periodically ot update your survey information. Participants will recieve annual newsletters about ongoing research from Cancer Prevention Studies.

What CPS-3 is NOT

CPS-3 is not a clinical trial or experiment. Researchers will not ask participants to take pills, change their lifestyle, or receive treatments of any kind. Clinical testing will not be conducted on participants, thus there will be no diagnoses or screenings for medical conditions.

CPS-3 is not a paid study. Participation is completely voluntary, and there is no financial cost to participants . All follow-up study materials are mailed to participants.

CPS-3 is not sponsored by the government. The American Cancer Society funds and operates CPS-3

 

Our Commitment to Confidentiality

Confidentiality is of the utmost importance to us and we will make every effort to protect the privacy of study participants. We have multiple procedures in place to safeguard your personal information.

Remember to enroll in the CPS-3 Study on April 9, 2010 at the Regional Convention.

 

 

 

 

 

 

Breast cancer is the most common type of
cancer diagnosed in American women
and the second leading cause of cancer death